Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus

ClinicalTrials.gov ID: NCT06100939

Public ClinicalTrials.gov record NCT06100939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus (APRICITY-A)

Study identification

NCT ID
NCT06100939
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Epion Therapeutics
Industry
Enrollment
396 participants

Conditions and interventions

Conditions

Interventions

  • Riboflavin and Sodium Iodide solution and Ultraviolet-A treatment Combination Product
  • Placebo and sham treatment Combination Product

Combination Product

Eligibility (public fields only)

Age range
8 Years to 45 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 29, 2023
Primary completion
May 26, 2026
Completion
Jun 11, 2026
Last update posted
Jun 24, 2026

2023 – 2026

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Nvision Eye Centers Rowland Heights Rowland Heights California 91748
Goodman Eye Center San Francisco California 94115
Center for Excellence in Eye Care Miami Florida 33176
Chicago Cornea Consultants Hoffman Estates Illinois 60169
Boston Vision Brookline Massachusetts 02445
Ophthalmology Associates St Louis Missouri 63131
The Eye Doctors at CNY Eye Care East Syracuse New York 13057
Cincinnati Eye Institute Cincinnati Ohio 45219
Devers Eye Institute Portland Oregon 97210
Wills Eye Hospital Philadelphia Pennsylvania 19107
UPMC Vision Institute Pittsburgh Pennsylvania 15219
Baylor College of Medicine Houston Texas 77030
University of Virginia Charlottesville Virginia 22903

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06100939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06100939 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →